Home › NDC Lookup › Ingredients › Fexofenadine Hydrochloride › 61269-0527-94
Childrens Allergy fexofenadine hydrochloride 30 mg/5mL Suspension — NDC 61269-0527-94 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Childrens Allergy fexofenadine hydrochloride 30 mg/5mL Suspension — NDC 61269-527-94 (Billing 61269-0527-94)

by H2-Pharma, LLC · 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE

This is a package of Childrens Allergy fexofenadine hydrochloride 30 mg/5mL Suspension from H2-Pharma, LLC, marketed since Jul 2022 and currently FDA-listed, this package's marketing is listed to end Jun 2027; retail pharmacies pay about $0.1192 per mL (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 61269-0527-94
🏷️ FDA NDC (as labeled) 61269-527-94 billing pads the product segment with a zero
This package
Contains118 mL in 1 bottle Cost per mL$0.1192 NADAC Per package$14.07 / 118 ml Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.0782/unit — full pricing hub ↓
Main listing for product 61269-527 · Also comes in: 237 mL 61269-527-98
OTC Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 61269-527-94 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
61269 labeler · 527 product · 94 package
Package marketed since
Jul 18, 2022
Package marketing ended
Jun 30, 2027
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 6126952794 4
Medicaid fills, this package
9,282 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 61269-527-94
Product NDC 61269-527
11-digit billing NDC 61269052794
NCPDP billing unit ML — per mL (volume)
RxCUI 997491
UNII 2S068B75ZU
Application # ANDA203330
SPL Set ID 84988f6d-85b1-45dd-89be-0333acc6b180
Established class (EPC) Histamine-1 Receptor Antagonist
Mechanism of action Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-07-18
Marketing end 2027-06-30
Route ORAL
Dosage form SUSPENSION
Substance FEXOFENADINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 061995
GCN 97779
HICL code 011595
Ingredient (HICL) Fexofenadine Hcl
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2Q
Therapeutic class — specific (HIC3) Antihistamines - 2Nd Generation
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name CHILD ALLERGY (FEXO) 30 MG/5ML
FDB brand name Children's Allergy
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 061995
  • GCN: 97779
  • HICL (First Databank): 011595
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 997491
Why two NDCs? The FDA registers this code as 61269-527-94 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 61269-0527-94. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Other antihistamines for systemic use
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CHILD ALLERGY (FEXO) 30 MG/5ML Ingredient Fexofenadine Hcl
📖 What it is MedlinePlus · NLM

Fexofenadine is used to treat allergy symptoms: runny nose sneezing red, itchy, or watering eyes itching of the nose or throat It is also used to treat itching and redness caused by hives. Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It relieves hay fever and other upper respiratory allergy symptoms like runny nose, sneezing, and itchy, watery eyes. Some products, like Allegra Hives 24hr, are for hives and the...
  • No. The label says not to take it with fruit juices, so use water instead. Also avoid taking it at the same time as aluminum or magnesium antacids.
  • Can I take fexofenadine with fruit juice?
  • Yes, check with your doctor first. The label says your doctor should decide whether you need a different dose. The same goes for adults 65 and older.
📖 Read our full Fexofenadine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.119 $14.07 / 118 ml
Medicaid paysCMS SDUD · 12 mo $0.0782 $9.23 / 118 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.119 $0.060
▲ Up 98% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
61269-0527-94 You're viewing this Main listing 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE $0.1192 / mL $14.07 2022-07-18 Jun 30, 2027 Active
61269-0527-98 61269-527-98 1 BOTTLE in 1 CARTON / 237 mL in 1 BOTTLE — — 2022-07-18 — Discontinued by firm

In Medicaid, this is the most-dispensed pack of this product — about 97% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 bottle in 1 carton / 118 ml in 1 bottle.
What NDC number is used to bill for this package of Childrens Allergy fexofenadine hydrochloride 30 mg/5mL Suspension?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Childrens Allergy 30 mg/5mLthis 61269-0527-94 H2-Pharma, 1 bottle $0.119 — Availability likely —
Childrens Fexofenadine Hydrochloride Allergy 30 mg/5mL 00363-2141-01 Walgreens 1 bottle — — FDA listed —
Children Allergy 30 mg/5mL 00363-2600-04 Walgreens 1 bottle — — FDA listed —
Dye Free Wal Fex childrens allergy 30 mg/5mL 00363-9230-04 Walgreens 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 37808-0623-04 H 1 bottle — — FDA listed —
Children Allergy 30 mg/5mL 37808-0654-04 H 1 bottle — — FDA listed —
Childrens Allegra Hives 30 mg/5mL 41167-4227-01 Chattem, 1 bottle — — FDA listed —
Childrens Allegra Allergy 30 mg/5mL 41167-4244-01 Chattem, 1 bottle — — FDA listed —
Childrens Allegra Allergy 30 mg/5mL 41167-4246-02 Chattem, 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 49035-0208-04 EQUATE 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 51316-0260-04 CVS 1 bottle — — FDA listed —
Childrens Fexofenadine Hydrochloride Allergy 30 mg/5mL 51672-2141-01 Sun 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 55319-0923-04 Family 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 55319-0957-04 Family 1 bottle — — Discontinued —
Fexofenadine Hydrochloride 30 mg/5mL 58602-0426-20 Aurohealth 1 bottle — — FDA listed —
Childrens Allergy 30 mg/5mL 79903-0249-04 WALMART 1 bottle — — FDA listed —
Childrens Fexofenadine Hydrochloride Allergy 30 mg/5mL 79903-0306-04 Wal-Mart 1 bottle — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2022
On the market since
Jul 2022
📍
2026
Currently FDA-listed
4 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Fexofenadine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3QPI1U3FV8
    A preservative derived from benzoic acid that prevents bacterial and fungal growth in medicines. It helps extend shelf life and maintain product safety during storage and use.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII TUF2IVW3M2
    Poloxamer 407 is a synthetic polymer made from ethylene oxide and propylene oxide. In medicines, it acts as a thickener, emulsifier, and solubilizer to help mix ingredients and create the right texture.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 22ADO53M6F
    A mineral salt derived from phosphoric acid, used as a buffer to maintain the pH balance of the medication and help stabilize the active ingredients.
  • UNII KH7I04HPUU
    A salt compound made from sodium and phosphoric acid, used as a buffer to help maintain a stable pH level in the medicine, and sometimes as a binder or filler in tablets and capsules.
  • UNII C151H8M554
    A natural sugar derived from sugar cane or sugar beets. It's used as a sweetener, filler, and binder to improve taste, add bulk, and help hold tablet or capsule ingredients together.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.
  • UNII VCQ006KQ1E
    Xylitol is a naturally occurring sugar alcohol derived from plants. It's used in medicines as a sweetener, bulking agent, and to improve taste, especially in liquid formulations and chewable tablets.

12 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesartificial raspberry flavor, butylparaben, edetate disodium, poloxamer 407, propylene glycol, propylparaben, purified water, sodium phosphate dibasic, sodium phosphate monobasic, sucrose, titanium dioxide, xanthan gum, xylitol

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerH2-Pharma, LLC
Application holderP AND L DEVELOPMENT LLC
FDA applicationANDA203330 (ANDA)
Labeler code61269
First marketedJul 2022
Product typeHuman Otc Drug
Portfolio27 products on file

More NDCs from H2-Pharma, LLC labeler code 61269

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 26 words ▾

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

⏱️ Dosage and Administration 90 words ▾

Directions shake well before using use only with enclosed dosing cup Note: mL = milliliters adults and children 12 years of age and over take 10 mL every 12 hours; do not take more than 20 mL in 24 hours children 2 to under 12 years of age take 5 mL every 12 hours; do not take more than 10 mL in 24 hours children under 2 years of age ask a doctor adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

⚠️ Warnings 122 words ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have kidney disease. Your doctor should determine if you need a different dose.

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions ) Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📦 Storage and Handling 31 words ▾

Other information each 5 mL contains: sodium 18 mg store between 20° to 25°C (68° to 77°F) before using any medication, read all label directions. Keep carton, it contains important information.

🧪 Active Ingredient 11 words ▾

Active ingredient (in each 5 mL) Fexofenadine HCl, USP 30 mg

🧪 Inactive Ingredients 27 words ▾

Inactive ingredients artificial raspberry flavor, butylparaben, edetate disodium, poloxamer 407, propylene glycol, propylparaben, purified water, sodium phosphate dibasic, sodium phosphate monobasic, sucrose, titanium dioxide, xanthan gum, xylitol

🎯 Purpose 2 words ▾

Purpose Antihistamine

📄 Do Not Use 19 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

📄 Ask a Doctor Before Use If 20 words ▾

Ask a doctor before use if you have kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 31 words ▾

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions )

📄 Stop Use and Ask a Doctor If 19 words ▾

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

📄 Questions or Comments 8 words ▾

Questions or comments? Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

📄 Package Label / Principal Display Panel 85 words ▾

PRINCIPAL DISPLAY PANEL - 237 mL Bottle Carton NDC 61269-527-98 *Compare to the active ingredient in Children's Allegra® Allergy Children's Allergy Fexofenadine HCl Oral Suspension 30 mg/5 mL Antihistamine Indoor/Outdoor allergy relief Sneezing Runny nose Itchy, watery eyes Itchy nose or throat 12 Hour Relief Ages 2 years and older Non-drowsy Dye-free Alcohol-free Use only with enclosed dosing cup. Wash and let air dry after each use. BERRY FLAVOR 8 fl oz (237 mL) H 2 pharma PRINCIPAL DISPLAY PANEL - 237 mL Bottle Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
9.3K
Units reimbursed last 4 qtrs
2.1M
Gross reimbursed last 4 qtrs
$166.4K
Avg / prescription
$17.92
Avg / unit
$0.0782
Latest quarter Q1 2026
2.7KRx
Medicaid pays / mL
$0.0782
gross reimbursed
vs
NADAC / mL
$0.1192
acquisition cost
=
Spread
−$0.0410
-34% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
27% FFS 73% MCO
Fee-for-service · 2,547 Rx Managed care · 6,735 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 23,879 units · 416 per 100k residents MN Wisconsin: 7,009 units · 119 per 100k residents WI Michigan: 151,936 units · 1,514 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: 4,607 units · 329 per 100k residents NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 94,989 units · 1,384 per 100k residents IN Ohio: 161,313 units · 1,369 per 100k residents OH Pennsylvania: 351,449 units · 2,712 per 100k residents PA New Jersey: 69,167 units · 745 per 100k residents NJ Massachusetts: no data reported MA California: 127,236 units · 327 per 100k residents CA Utah: no data reported UT Colorado: 10,529 units · 179 per 100k residents CO Nebraska: no data reported NE Missouri: 78,582 units · 1,268 per 100k residents MO Kentucky: 221,710 units · 4,899 per 100k residents KY West Virginia: 55,630 units · 3,143 per 100k residents WV Virginia: 72,314 units · 830 per 100k residents VA Maryland: 169,915 units · 2,749 per 100k residents MD Connecticut: 100,524 units · 2,779 per 100k residents CT Rhode Island: 12,860 units · 1,174 per 100k residents RI Arizona: 37,289 units · 502 per 100k residents AZ New Mexico: 6,788 units · 321 per 100k residents NM Kansas: 21,932 units · 746 per 100k residents KS Arkansas: no data reported AR Tennessee: 7,558 units · 106 per 100k residents TN North Carolina: 16,775 units · 155 per 100k residents NC South Carolina: 83,321 units · 1,551 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: 5,463 units · 119 per 100k residents LA Mississippi: no data reported MS Alabama: 114,230 units · 2,236 per 100k residents AL Georgia: 98,265 units · 891 per 100k residents GA D.C.: 21,625 units · 3,185 per 100k residents DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
1064,899
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Kentucky 4,899 /100k
2 D.C. 3,185 /100k
3 West Virginia 3,143 /100k
4 Connecticut 2,779 /100k
5 Maryland 2,749 /100k
6 Pennsylvania 2,712 /100k
7 Alabama 2,236 /100k
8 South Carolina 1,551 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 bottle this page61269-0527-94 9,282 Rx · $166,352
1 bottle61269-0527-98 258 Rx · $4,891
Drug total (last 4 qtrs): 9,540 Rx · 2,191,994 units · $171,243 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 61269-0518-12 · H2-Pharma 61269-0565-90 · H2-Pharma →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.